MKS (NASDAQ:MKSI) Price Target Raised to $258.00 at Morgan Stanley

MKS (NASDAQ:MKSI) had its target price hoisted by equities research analysts at Morgan Stanley from $187.00 to $258.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the scientific and technical instruments company’s stock. Morgan Stanley’s price objective points to a potential upside of 17.07% from the stock’s previous close.

Other equities analysts have also recently issued reports about the stock. Needham & Company LLC lifted their price target on shares of MKS from $210.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Company boosted their target price on MKS from $175.00 to $210.00 and gave the company an “equal weight” rating in a research note on Thursday. Wall Street Zen cut MKS from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 3rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of MKS in a research note on Thursday. Finally, The Goldman Sachs Group lifted their price target on shares of MKS from $92.00 to $125.00 and gave the company a “sell” rating in a research note on Thursday, October 9th. Ten equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, MKS presently has an average rating of “Moderate Buy” and an average target price of $220.25.

MKS Trading Down 0.2%

Shares of MKS stock traded down $0.35 during trading on Thursday, reaching $220.39. 418,410 shares of the company were exchanged, compared to its average volume of 1,084,670. The business has a 50-day moving average price of $166.29 and a 200-day moving average price of $134.80. The firm has a market capitalization of $14.80 billion, a price-to-earnings ratio of 53.47, a P/E/G ratio of 1.94 and a beta of 1.92. The company has a quick ratio of 1.81, a current ratio of 2.86 and a debt-to-equity ratio of 1.64. MKS has a twelve month low of $54.84 and a twelve month high of $233.11.

MKS (NASDAQ:MKSI) last issued its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.80 by $0.13. The firm had revenue of $988.00 million for the quarter, compared to analysts’ expectations of $963.87 million. MKS had a return on equity of 20.80% and a net margin of 7.25%.The company’s revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.72 earnings per share. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Sell-side analysts anticipate that MKS will post 6.94 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Elizabeth Mora sold 300 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total value of $47,643.00. Following the transaction, the director owned 18,963 shares of the company’s stock, valued at approximately $3,011,514.03. This represents a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB grew its position in MKS by 6.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 898 shares of the scientific and technical instruments company’s stock worth $144,000 after acquiring an additional 58 shares during the last quarter. Brighton Jones LLC boosted its stake in shares of MKS by 2.4% during the third quarter. Brighton Jones LLC now owns 3,462 shares of the scientific and technical instruments company’s stock valued at $428,000 after purchasing an additional 82 shares in the last quarter. MAI Capital Management grew its holdings in shares of MKS by 10.6% during the third quarter. MAI Capital Management now owns 1,057 shares of the scientific and technical instruments company’s stock worth $131,000 after purchasing an additional 101 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in shares of MKS by 74.5% in the third quarter. Smartleaf Asset Management LLC now owns 260 shares of the scientific and technical instruments company’s stock valued at $32,000 after buying an additional 111 shares during the period. Finally, Larson Financial Group LLC increased its stake in shares of MKS by 26.6% in the third quarter. Larson Financial Group LLC now owns 533 shares of the scientific and technical instruments company’s stock valued at $66,000 after buying an additional 112 shares during the period. 99.79% of the stock is owned by institutional investors.

Key MKS News

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Cantor Fitzgerald raised its price target to $300 (overweight), driving substantial upside expectations and helping lift MKSI to new highs. Cantor Fitzgerald Boosts MKS Price Target to $300
• Positive Sentiment: Needham bumped its target to $260 and kept a buy rating, signaling continued analyst confidence in the company’s growth/cycle dynamics. Needham Raises MKSI Price Target to $260
• Positive Sentiment: Bank of America raised its target to $255 and set a buy rating, adding to the cluster of upward revisions that are supporting the stock’s rally. Benzinga Coverage
• Positive Sentiment: TD Cowen also lifted its target to $230 with a buy rating, reinforcing broad analyst upgrading across the sell-side.
• Positive Sentiment: MKSI has recently hit all-time / 52-week highs as the analyst upgrades accumulated, which often attracts momentum buyers. MKS Instruments stock hits all-time high
• Neutral Sentiment: MKS updated Q4 2025 guidance: revenue guidance is roughly in line or slightly above consensus (~$1.0B vs $994.1M consensus) while EPS guidance is effectively flat to marginally below consensus — a mixed signal that moderates upside.
• Neutral Sentiment: The company is meeting lenders about a comprehensive capital-structure refinancing (scheduled lender meetings), which could lower financing costs longer term but adds near-term execution and covenant risk. MKS Plans Comprehensive Capital Structure Refinancing With Lenders
• Negative Sentiment: High valuation and rapid run-up increase the risk of short-term profit-taking or volatility despite positive analyst commentary — investors should weigh upside from raised targets against rich multiples and execution risk.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.